Tamiflu

Showing 15 posts of 15 posts found.

800px-a_tamiflu_oseltamivir_capsule

Judge allows $1.5 billion Tamiflu stockpiling lawsuit against Roche to go ahead

September 30, 2020
Research and Development Roche, Tamiflu

A Maryland federal judge denied Roche’s motion to throw out a lawsuit that alleges the company defrauded the US and …

Roche’s Xofluza proves non-inferior to Tamiflu in children with flu

July 3, 2019
Research and Development Roche, Tamiflu, flu, pharma

Roche has unveiled new Phase 3 data indicating that Xofluza (baloxavir marboxil) was well-tolerated and of comparable efficacy to its …

Roche flu drug proves efficacy at Phase 3, but enough to beat Tamiflu generics?

July 17, 2018
Manufacturing and Production, Research and Development Roche, Tamiflu, baloxavir marboxil, flu, influenza, pharma

Roche is celebrating the news that its investigational influenza drug baloxavir marboxil performed well at Phase 3, meeting its primary …

flu

New flu med can destroy influenza virus in one day

February 13, 2018
Manufacturing and Production, Research and Development Roche, Shionongi, Tamiflu, biotech, drugs, flu, influenza, pharma, pharmaceutical

Researchers in Japan have achieved a notable success in a Phase 3 clinical trial to determine whether a new vaccine …

First generic copy of Roche’s Tamiflu hits US market

December 12, 2016
Sales and Marketing Alvogen, Roche, Tamiflu

Drugmaker Alvogen has released the first generic version of Roche’s flu medication Tamiflu (oseltamivir) in the US, where it expects …

Tamiflu image

Government spending on Tamfilu is justified

January 30, 2015
Research and Development, Sales and Marketing BMJ, Lancet, Roche, Tamiflu, alltrials, oseltamivir, transparency

The most thorough analysis of Roche’s Tamiflu to date suggests that the controversial treatment can shorten the duration of flu …

NICE seeks more trial data from pharma

September 10, 2014
Medical Communications, Research and Development, Sales and Marketing David Haslam, NICE, Tamiflu, alltrials, transparency

NICE is calling on pharma to release more data so it can better assess the costs of new medicines.The watchdog …

Jeremy Hunt

NICE to look again at Tamiflu after data saga

April 11, 2014
Medical Communications, Sales and Marketing Jeremy Hunt, Roche, Tamiflu

The UK government has asked NICE to review its guidance for Roche’s troubled pandemic flu medicine Tamiflu after a new …

Tamiflu

Tamiflu stockpiling ‘unjustifiable’ and wasted £424m

April 10, 2014
Medical Communications, Research and Development, Sales and Marketing BMJ, Cochrane, Tamiflu, alltrials

Governments around the world may have squandered hundreds of millions of pounds on stockpiling Tamiflu, according to a review by …

tamiflu image

Roche to release Tamiflu data

November 23, 2012
Sales and Marketing BMJ, Cochrane, Goldacre, NHS, Roche, Tamiflu

Roche has said it will let researchers have access to more data on its influenza vaccine Tamiflu, apparently under pressure …

GMP issues affect Mircera, Xenical production at Roche plant

January 31, 2012
Manufacturing and Production GMP, Mircera, Roche, Tamiflu, Xenical

Supply of two Roche products has been disrupted after an active pharmaceutical ingredient (API) production facility in the US was …

Tamiflu image

BMJ blasts Roche for withholding Tamiflu data

January 18, 2012
Research and Development, Sales and Marketing BMJ, EMA, Roche, Tamiflu, WHO

Roche is still withholding Tamiflu data from researchers, claims the British Medical Journal. Two years after Roche said it would …

Tamiflu windfall helps Roche to bumper sales growth

October 15, 2009
Sales and Marketing Roche, Tamiflu

 Roche has raised its sales growth prediction for 2009 on the back of a strong third quarter and record sales …

Latest content